Compare GERN & PSIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GERN | PSIX |
|---|---|---|
| Founded | 1990 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 935.1M |
| IPO Year | 1996 | 2011 |
| Metric | GERN | PSIX |
|---|---|---|
| Price | $1.36 | $41.86 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $2.17 | ★ $99.95 |
| AVG Volume (30 Days) | ★ 9.0M | 311.5K |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 51.85 | ★ 64.12 |
| EPS | N/A | ★ 1.05 |
| Revenue | $1,065,000.00 | ★ $416,616,000.00 |
| Revenue This Year | $26.91 | $24.73 |
| Revenue Next Year | $43.75 | $16.20 |
| P/E Ratio | ★ N/A | $40.08 |
| Revenue Growth | N/A | ★ 22.73 |
| 52 Week Low | $1.04 | $25.28 |
| 52 Week High | $2.01 | $119.16 |
| Indicator | GERN | PSIX |
|---|---|---|
| Relative Strength Index (RSI) | 40.83 | 56.80 |
| Support Level | $1.24 | $35.47 |
| Resistance Level | $1.46 | $43.89 |
| Average True Range (ATR) | 0.08 | 1.89 |
| MACD | -0.02 | 0.44 |
| Stochastic Oscillator | 3.85 | 59.41 |
Geron Corp is a biopharmaceutical company focused on blood cancers. Its telomerase inhibitor, RYTELO (imetelstat), is approved in the United States and European Union for certain adult patients with lower-risk myelodysplastic syndromes (LR-MDS) with transfusion-dependent anemia. RYTELO inhibits telomerase activity in malignant stem and progenitor cells, which may reduce abnormal cell proliferation while supporting the production of healthy cells. It is also conducting a Phase 3 trial of imetelstat in patients with JAK-inhibitor-refractory or relapsed myelofibrosis (R/R MF) and studies in other hematologic malignancies. The company operates as a single segment, being the development of therapeutic products for oncology.
Power Solutions International Inc is an America-based company that manufactures, distributes, and services power systems that run on nondiesel fuels, including natural gas, propane, and gasoline. The company's products are designed to meet emission standards imposed by environmental regulatory bodies like the Environmental Protection Agency. Its products are distributed to a wide range of industrial original equipment manufacturers that supply equipment to sectors including power generation, oil and gas, material handling, airport ground support, agricultural, turf, construction and irrigation. The company generates majority of its sales from United States, and also has its presence in North America (outside of United States), Pacific Rim, Europe and Others.